Yes, I fully agree with your statements, too.
Post# of 36537
(Total Views: 403)
Posted On: 04/12/2021 1:04:35 PM
Yes, I fully agree with your statements, too.
On the positive side of things, it is surely good to read, that ...
* they have made progress on the IND submission to the FDA, which includes that they have completed their "homework" (lab testing results, GMP, etc.)
* they emphazise on the fact that there will still be a market for the "Complete Vaccine" even if it won't be available before Q1 2022.
* they pointed out several times that the "Complete Vaccine" can be transported at room temperature in form of a simple powder to even the most remote locations of this planet.
* they believe that their ii-key Covid vaccine is likely going to be much versatily effective against multiple strains of the Corona virus, and I especially liked their line of thought comparing the effectiveness of their vaccine even against the SARS-I virus. This should give a lot of people a good idea how "complete" the NGIO Corona vaccine really is.
* the suggested long term immunity is based on lab results as well as their previous experience with the breast cancer vaccine, which proves the immunity even after 10 years.
Still, my issues with the PR, as stated before remain!
On the positive side of things, it is surely good to read, that ...
* they have made progress on the IND submission to the FDA, which includes that they have completed their "homework" (lab testing results, GMP, etc.)
* they emphazise on the fact that there will still be a market for the "Complete Vaccine" even if it won't be available before Q1 2022.
* they pointed out several times that the "Complete Vaccine" can be transported at room temperature in form of a simple powder to even the most remote locations of this planet.
* they believe that their ii-key Covid vaccine is likely going to be much versatily effective against multiple strains of the Corona virus, and I especially liked their line of thought comparing the effectiveness of their vaccine even against the SARS-I virus. This should give a lot of people a good idea how "complete" the NGIO Corona vaccine really is.
* the suggested long term immunity is based on lab results as well as their previous experience with the breast cancer vaccine, which proves the immunity even after 10 years.
Still, my issues with the PR, as stated before remain!
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼